{
    "medicine_id": "5319ccc3e58e719b3b22eb0678c037ca64921256",
    "platform_id": "DB04941",
    "metadata": {
        "name": "Fulyzaq 125 mg 1 Tablet coated",
        "composition": "125 mg 1 Crofelemer",
        "clinical_particulars": {
            "therapeutic_indications": "For the symptomatic treatment of non infectious diarrhea in adult patients with HIV AIDS who are taking antiretroviral therapy",
            "contraindications": {
                "disease": "The most common adverse effects are cough flatulence upper respiratory tract infection bronchitis and increased bilirubin",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Crofelemer is an inhibitor of secretory diarrhea via inhibition of the CFTR chloride transporter Crofelemer is not an antimicrobial and therefore does not drive the emergence of resistance it does not inhibit motility and therefore does not cause constipation or rebound diarrhea and it is not systemically absorbed reducing the potential for adverse drug interactions and toxicity",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}